OMOP Concept 37557352
Anti-CD20 radioimmunoconjugate
ClassificationDrugHemOnc119896Component Class
Maps from
0
Descendants
82
Valid from
19 Aug 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(12)Roll up to these when you need a wider cohort.
Narrower concepts
(82)Included automatically when you query with descendants.
- 2131Iodine-Tositumomab monotherapy
- 2(90)YFC
- 2(90)YFC (rituximab-abbs)
- 2(90)YFC (rituximab-arrx)
- 2(90)YFC (rituximab-blit)
- 2(90)YFC (rituximab-pvvr)
- 2(90)YFC (rituximab-rite)
- 2(90)YFC (rituximab-rixa)
- 2(90)YFC (rituximab-rixi)
- 2(90)YFC, then allo HSCT
- 2(90)YFC, then allo HSCT (rituximab-abbs)
- 2(90)YFC, then allo HSCT (rituximab-arrx)
- 2(90)YFC, then allo HSCT (rituximab-blit)
- 2(90)YFC, then allo HSCT (rituximab-pvvr)
- 2(90)YFC, then allo HSCT (rituximab-rite)
- 2(90)YFC, then allo HSCT (rituximab-rixa)
- 2(90)YFC, then allo HSCT (rituximab-rixi)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan (rituximab-abbs)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan (rituximab-arrx)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan (rituximab-blit)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan (rituximab-pvvr)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan (rituximab-rite)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan (rituximab-rixa)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan (rituximab-rixi)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT (rituximab-abbs)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT (rituximab-arrx)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT (rituximab-blit)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT (rituximab-pvvr)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT (rituximab-rite)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT (rituximab-rixa)
- 2Busulfan, Fludarabine, Ibritumomab tiuxetan, then allo HSCT (rituximab-rixi)
- 2CHOP, then 131Iodine-Tositumomab
- 2CVP, then 131Iodine-Tositumomab
- 2Fludarabine, then 131Iodine-Tositumomab
- 2ibritumomab tiuxetan 1.6 MG/ML
- 2ibritumomab tiuxetan 1.6 MG/ML [Zevalin]
- 2ibritumomab tiuxetan Injectable Solution
- 2ibritumomab tiuxetan Injectable Solution [Zevalin]
- 2Ibritumomab tiuxetan protocol
- 2Ibritumomab tiuxetan protocol (rituximab-abbs)
- 2Ibritumomab tiuxetan protocol (rituximab-arrx)
- 2Ibritumomab tiuxetan protocol (rituximab-blit)
- 2Ibritumomab tiuxetan protocol (rituximab-pvvr)
- 2Ibritumomab tiuxetan protocol (rituximab-rite)
- 2Ibritumomab tiuxetan protocol (rituximab-rixa)
- 2Ibritumomab tiuxetan protocol (rituximab-rixi)
- 2iodine-131-tositumomab 0.1 MG/ML
- 2iodine-131-tositumomab 1.1 MG/ML
Get this concept via the API
Resolve Anti-CD20 radioimmunoconjugate - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/37557352?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card